Clinicopathologic analysis of cutaneous lymphoma in Taiwan: A high frequency of extranodal natural killer/T-cell lymphoma, nasal type, with an extremely poor prognosis

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 7, 2010, Pages 996-1002

  Liao, Jia Bin ^a,d   Chuang, Shih Sung ^b,c   Chen, Hsiu Chiung ^a   Tseng, Hui Hwa ^a   Wang, Jyh Seng ^a   Hsieh, Pin Pen ^a,d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Yuh Ing Junior College of Health Care and Management   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TUMOR; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; KILLER CELLS, NATURAL; LYMPHOMA; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TAIWAN; YOUNG ADULT;

EID: 75049083488     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92(15):1240-1251.
2. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90(1):354-371.
3. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
4. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32(10):647-674.
5. LeBoit PE, Burg G., Weedon D, Sarasin A, eds. Pathology and Genetics of Skin Tumours. 3rd ed. Lyon, France: IARC Press; 2006. World Health Organization Classification of Tumours; vol 10.
6. Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol. 2008;39(4):473-483.
7. Chang YT, Liu HN, Chen CL, Chow KC. Detection of Epstein-Barr virus and HTLVI in T-cell lymphomas of skin in Taiwan. Am J Dermatopathol. 1998;20(3):250-254.
8. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-768.
9. Yasukawa K, Kato N, Kodama K, Hamasaka A, Hata H. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization classification. J Cutan Pathol. 2006;33(7):487-491.
10. Tan SH, Sim CS, Ong BH. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems. Br J Dermatol. 2003;149(3):542-553.
11. Nagasawa T, Miwa H, Nakatsuka S, Itami S, Yoshikawa K, Aozasa K. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification. Am J Dermatopathol. 2000;22(6):510-514.
12. Tan MW. Korean Dermatopathology Research Group. Characteristics of cutaneous lymphomas in Korea. Clin Exp Dermatol. 2003;28(6):639-646.
13. Liang R, Chiu E, Loke SL, Chan TK, Todd D, Ho F. Primary and secondary cutaneous lymphomas in Hong Kong Chinese. Hematol Oncol. 1990;8(6):333-338.
14. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008. World Health Organization Classification of Tumours; vol 2.
15. Fink-Puches R, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood. 2002;99(3):800-805.
16. Chuang SS, Lin CN, Shen FC, et al. Detecting clonal rearrangement in non-Hodgkin's lymphomas in Taiwan by polymerase chain reaction. Leuk Lymphoma. 2003;44(1):117-121.
17. Lee MY, Tan TD, Feng AC, Liu MC. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. Am J Hematol. 2006;81(8):568-575.
18. Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer. 2000;85(3):319-324.
19. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-6068.
20. Ko YH, Kim CW, Park CS, et al. Hematolymphoreticular Study Group of the Korean Society of Pathologists. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Cancer. 1998;83(4):806-812.
21. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89(11):3909-3918.
22. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50(9):696-702.
23. Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood. 1997;89(12):4514-4520.
24. Hsieh PP, Tung CL, Chan AB, et al. EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma. Am J Clin Pathol. 2007;128(4):579-584.
25. Lu D, Lin CN, Chuang SS, Hwang WS, Huang WT. T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk Lymphoma. 2004;45(5):923-928.
26. Lee MY, Tsou MH, Tan TD, Lu MC. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma. Eur J Haematol. 2005;75(3):221-226.
27. Kuo TT, Shih LY, Tsang NM. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004;12(4):375-387.
28. Van Gorp J, De Bruin PC, Sie-Go DM, et al. Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology. 1995;27(2):139-148.
29. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16(1):70-77.
30. Cho KH, Choi WW, Youn CS, Kim CW, Heo DS. Skin is the frequent site for involvement of peripheral T-cell and natural killer cell lymphomas in Korea. Journal of Dermatology. 2000;27(8):500-507.
31. Yoshino T, Nakamura S, Suzumiya J, et al. Expression of cutaneous lymphocyte antigen is associated with a poor outcome of nasal-type natural killer-cell lymphoma. Br J Haematol. 2002;118(2):482-487.
32. Tsuchiyama J, Yoshino T, Toba K, et al. Induction and characterization of cutaneous lymphocyte antigen on natural killer cells. Br J Haematol. 2002;118(2):654-662.
33. Alon R, Rossiter H, Wang X, Springer TA, Kupper TS. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J Cell Biol. 1994;127(5):1485-1495.
34. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphomawith cutaneous involvement. J AmAcadDermatol. 1999;40(5, pt 2):850-856.